IRIS
FARGNOLI, MARIA CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.374
AS - Asia 8.372
EU - Europa 7.916
SA - Sud America 1.042
AF - Africa 130
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 16
Totale 32.871
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.170
SG - Singapore 3.621
IE - Irlanda 1.839
RU - Federazione Russa 1.799
CN - Cina 1.688
HK - Hong Kong 889
BR - Brasile 875
TR - Turchia 875
SE - Svezia 811
VN - Vietnam 783
DE - Germania 752
GB - Regno Unito 568
IT - Italia 549
UA - Ucraina 489
FR - Francia 369
FI - Finlandia 345
IN - India 133
CA - Canada 105
NL - Olanda 75
JP - Giappone 71
ES - Italia 66
MX - Messico 65
AR - Argentina 59
CZ - Repubblica Ceca 50
BD - Bangladesh 44
BE - Belgio 44
ZA - Sudafrica 44
PL - Polonia 43
IQ - Iraq 36
ID - Indonesia 27
LT - Lituania 26
PK - Pakistan 24
MA - Marocco 23
CO - Colombia 21
EC - Ecuador 21
AT - Austria 19
EU - Europa 18
UZ - Uzbekistan 18
KE - Kenya 16
KR - Corea 16
PE - Perù 16
JO - Giordania 15
VE - Venezuela 15
AU - Australia 14
MY - Malesia 14
CL - Cile 13
IL - Israele 13
AZ - Azerbaigian 11
SA - Arabia Saudita 11
PY - Paraguay 10
TN - Tunisia 10
TW - Taiwan 10
PH - Filippine 9
RO - Romania 9
HN - Honduras 8
HU - Ungheria 8
TH - Thailandia 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
BY - Bielorussia 7
DZ - Algeria 7
EG - Egitto 7
LB - Libano 7
NP - Nepal 7
CR - Costa Rica 6
KZ - Kazakistan 6
RS - Serbia 6
TT - Trinidad e Tobago 6
GE - Georgia 5
KG - Kirghizistan 5
SN - Senegal 5
AL - Albania 4
CH - Svizzera 4
DK - Danimarca 4
JM - Giamaica 4
LU - Lussemburgo 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
EE - Estonia 3
KH - Cambogia 3
MD - Moldavia 3
MK - Macedonia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CY - Cipro 2
GM - Gambi 2
GR - Grecia 2
GT - Guatemala 2
LC - Santa Lucia 2
ME - Montenegro 2
MN - Mongolia 2
NO - Norvegia 2
PA - Panama 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
Totale 32.840
Salva come PNG Salva come JPEG
Città #
Singapore 2.086
Chandler 1.944
Jacksonville 1.918
Dublin 1.835
Dallas 1.593
San Jose 1.516
Hong Kong 873
Ashburn 824
Santa Clara 798
Boardman 692
The Dalles 491
Izmir 425
Moscow 353
New York 352
Nanjing 338
Princeton 307
Lawrence 306
San Mateo 304
Wilmington 297
Ho Chi Minh City 248
Council Bluffs 217
Lauterbourg 212
Beijing 193
Hanoi 185
Los Angeles 164
Ann Arbor 156
Milan 131
Munich 123
Woodbridge 113
Nanchang 108
Columbus 103
São Paulo 98
Hefei 97
Des Moines 90
Mountain View 80
Seattle 74
Shenyang 73
Helsinki 66
Tokyo 64
Orem 63
Lappeenranta 57
Tianjin 57
Amsterdam 56
Hebei 55
Verona 54
Frankfurt am Main 52
L'aquila 50
Rome 50
Falls Church 48
Brno 45
Brussels 43
London 43
Kunming 42
Brooklyn 41
Jiaxing 41
Jinan 40
Warsaw 40
Stockholm 39
Dearborn 37
Atlanta 36
Montreal 36
Shanghai 36
Dong Ket 35
Norwalk 34
Denver 32
Da Nang 31
Boston 30
Changsha 29
Chennai 29
Falkenstein 29
Ningbo 29
Turku 28
Chicago 27
San Francisco 27
Houston 26
Belo Horizonte 25
Johannesburg 25
Manchester 24
Nuremberg 24
Phoenix 24
Zhengzhou 23
Guangzhou 22
Haiphong 22
L’Aquila 22
Brasília 21
Mexico City 21
Rio de Janeiro 21
Pune 20
Ankara 19
Bremen 18
Fremont 17
Hải Dương 17
Jakarta 17
Mumbai 17
Changchun 16
Taizhou 16
Tashkent 16
Toronto 16
Hangzhou 15
Nairobi 15
Totale 21.787
Salva come PNG Salva come JPEG
Nome #
Cutaneous metastatic breast carcinoma: A study of 164 patients 230
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 178
Rapid response of scalp psoriasis to ustekinumab 157
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases 148
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 147
Staging and follow-up of cutaneous Melanoma patients 145
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 144
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 143
A variant in FTO shows association with melanoma risk not due to BMI 140
Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy 138
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 137
Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features 134
T-cell receptor (TCR) signal transduction: Biochemical mechanisms and possible clinical implications 134
Understanding the molecular genetics of basal cell carcinoma 134
EDNRB gene variants and melanoma risk in two southern European populations. 134
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment 134
Cutaneous manifestations in Italian kidney transplant recipients 134
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 134
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients 132
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 132
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 131
Exploring the interplay of atopic dermatitis severity with sleep and mental health: a case-control study in adult patients 129
Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp 129
The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative 129
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project 125
Telomeres and telomerase in cutaneous squamous cell carcinoma 125
MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair 124
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 124
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family 124
Early stage melanoma diagnosis and mental health-related: emotional influence of body self-perception 124
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients 124
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 123
Diminished TCR signaling in cutaneous T-cell Iymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk 121
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study 121
On the interplay of telomeres, nevi and the risk of melanoma 120
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study 120
Hypo-epiluminescence microscopy of pigmented skin lesions. A new approach to improve recognition of dermoscopic structures 119
Dermoscopic features of actinic keratosis 119
Mucosal involvement in a patient with lymphomatoid papulosis 118
Efficacy, tolerability and cosmetic acceptabilily of Toléderm® in patients with inflammatory cutaneous diseases of the face 117
Pigmented reticular structures in basal cell carcinoma and collision tumours 117
Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R 117
Cutaneous and mucosal melanomas of uncommon sites: Where do we stand now? 117
Early Diagnosis of Melanoma and Breast Cancer in Women: Influence of Body Image Perception 116
Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis 116
Parapsoriasi 116
The spectrum of dermatoscopic patterns in blue nevi 116
Genetic Susceptibility In Familial And Multiple Melanoma Patients In Central Italy 116
Clinical experience of imiquimod 3.75% for actinic keratosis: Results from a case series 116
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 116
Molecular alterations in basal cell carcinoma subtypes 116
Treatments of advanced basal cell carcinoma: a review of the literature 115
Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis 115
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity 115
Basal cell carcinoma and inflammation: role of the Gadd45b gene 115
MC1R Variants Increase Risk of Melanomas harboring BRAF Mutations 115
Pilotropic mycosis fungoides presenting as an acneiform eruption 114
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 114
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 113
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy 113
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019 113
Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population 112
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families 112
The use of chemical peelings in the treatment of different cutaneous hyperpigmentations 112
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 111
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis 111
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy 111
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 111
Mycosis fungoides. Clinical and molecular biology observations 110
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysis 110
Interferon-beta injection site reactions in patients with multiple sclerosis 110
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 110
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 110
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant 109
Dermoscopic evolution of a congenital combined nevus in childhood 109
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma 109
Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation 109
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 109
Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype 108
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy 108
Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas 108
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts 107
Use of recombinant interferon alpha-2a in the treatment of squamous cell carcinoma 107
Comprehensive Evaluation of Allele Frequency Differences of MC1R Variants Across Populations 107
Reduced expression of CDKN2a/p16INK4a in mycosis fungoides 107
Knowledge of melanoma and attitude towards moles in Italian melanoma 107
Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location 107
Family history of psoriasis and age at disease onset in Italian patients with psoriasis 107
CDKN2A/p16 expression in mycosis fungoides 106
Occurrence of multiple melanomas in a patient with punctate palmoplantar keratoderma type-1A associated to alpha and gamma adaptin binding protein 105
Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients 105
Nail and enthesis assessment in patients with psoriatic disease by high frequency ultrasonography: findings from a single-centre cross-sectional study 104
Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk 104
p16(INK4a) and pl9(ARF) germline mutations in familial melanoma 104
Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin 104
Rare bone toxicity associated with vismodegib 104
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma 104
"Your Skin Tells You" Campaign for keratinocyte cancers: when individuals' selection makes the difference 103
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History 103
Clinical Trial on Aveeno Skin Relief Moisturizing Lotion in patients with itching accompanied by skin lesions and xerosis 103
Totale 11.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021680 0 0 0 0 0 0 0 0 0 99 452 129
2021/20221.694 96 128 308 108 56 39 23 104 175 17 131 509
2022/20235.428 394 290 94 546 454 608 4 399 2.354 31 173 81
2023/20241.397 210 67 147 204 88 355 42 52 1 64 31 136
2024/20256.230 165 108 590 222 734 573 902 480 1.440 200 450 366
2025/202611.413 540 1.061 1.118 1.346 1.190 783 2.381 613 1.130 1.251 0 0
Totale 33.399